Stephen V Liu, MD ✓

@StephenVLiu

Thoracic Oncologist, Chief of Heme/Onc @Georgetown @MedStarGUH, Head of Developmental Therapeutics @LombardiCancer, #DCLung26 #TexasLung27 #HereWeGo #LetsGoBucs

30 571Followers

3 632Following

23 402Posts total

18KViews on collected posts

Son gönderiler

Stephen V Liu, MD ✓@StephenVLiu14 Sep

@StephenVLiu @RManochakian @alexdrilon @IASLC Wonderful discussant @Mal_Itchins 🙌 Bringing it back to the patients who are thriving today because of access to trials and novel agents. Keep on pushing! https://t.co/7G6W2PHtRB

165 views · 5 likes · 0 reposts · 0 replies Open on X →

Stephen V Liu, MD ✓@StephenVLiu14 Sep

#WCLC26 Safety profile consistent with ROS1 selectivity. TRAEs in ≥15% of pts included edema, weight gain, blood CPK, dysgeusia, and AST elevation with few G3 TRAEs and discontinuation rate due to TEAE was 4%. https://t.co/41XjEbcMCF

725 views · 5 likes · 0 reposts · 0 replies Open on X →

Stephen V Liu, MD ✓@StephenVLiu14 Sep

Dr. @alexdrilon at #WCLC26 presents 1L cohort of ARROS-1 trial of zidesamtinib in pts with ROS1 NSCLC. What a waterfall plot. RR 94% with 15% CR. mPFS not reached, PFS at 6m was 96% and at 12m was 90%. Intracranial RR 100%. In 78 pts who did not have brain metastases at baseline,

10.1K views · 96 likes · 35 reposts · 4 replies Open on X →

Stephen V Liu, MD ✓@StephenVLiu12 Sep

@StephenVLiu @DRCamidge @LudaBazhenovaMD @TommyJohn00 @susu_mail0513 @IASLC Well deserved. His work on ALK-driven lung cancer changed outcomes for patients worldwide. Always great to see him recognized like this. 53 views · 0 likes · 0 reposts · 0 replies Open on X →

Stephen V Liu, MD ✓@StephenVLiu12 Sep

@StephenVLiu @DRCamidge @LudaBazhenovaMD @TommyJohn00 @susu_mail0513 @IASLC Congrats @DRCamidge!! 68 views · 0 likes · 0 reposts · 0 replies Open on X →

Stephen V Liu, MD ✓@StephenVLiu12 Sep

Powerful words praising @DRCamidge at #WCLC26 from @LudaBazhenovaMD @TommyJohn00 @susu_mail0513 echoed by all of us. @IASLC 3.5K views · 57 likes · 11 reposts · 2 replies Open on X →

Stephen V Liu, MD ✓@StephenVLiu12 Sep

Standing ovation in support and recognition of Dr Ross Camidge at #WCLC2026 https://t.co/RtTzRAiL7d

3.4K views · 28 likes · 7 reposts · 0 replies Open on X →

Aynı büyüklükteki hesaplara karşı

Son 90 güne ait 7 gönderi, 10K–100K takipçi aralığıyla yan yana. hem erişimde hem etkileşimde benzerlerinin altında.

Medyan görüntülenme725bu hesap92410K–100K için medyan

Erişim, %2.37%bu hesap3.62%10K–100K için medyan

Etkileşim, %1.04%bu hesap1.52%10K–100K için medyan

Ölçüt	Bu hesap	10K–100K için medyan	Oran
Gönderi başına medyan görüntülenme	725	924	0.78×
Erişim (görüntülenme ÷ takipçi)	2.37%	3.62%	0.66×
Etkileşim oranı	1.04%	1.52%	0.69×

Bu aralıktaki diğer hesaplar → Başka bir hesapla karşılaştır → Bu kıyas değerleri nasıl kuruluyor →

Growth & engagement

How the posts we collected actually performed: views and reaction rate post by post, what the audience did with them, and where the follower count goes.

Views per post

3.4K12 Sep

3.5K

10.1K14 Sep

725

165

Last 7 collected posts, oldest on the left. The scale is logarithmic: one post can outrun the rest a hundred times over.

Engagement rate per post

1.04%12 Sep

2.01%

0.00%

1.38%14 Sep

0.69%

3.03%

Reactions — likes, reposts, replies and quotes — divided by views. Median for 10K–100K accounts is 1.52%.

What the audience does

Likes69.7%191 in total

Reposts19.3%53 in total

Replies2.2%6 in total

Quotes1.8%5 in total

Bookmarks6.9%19 in total

Share of every reaction we collected for this account. Replies mean argument, reposts mean endorsement, bookmarks mean the post was worth keeping.

Followers by day

13 Sep

Daily snapshots since 13 Sep 2026; the dashed line is the starting count.

Son gönderiler

Aynı büyüklükteki hesaplara karşı

Growth & engagement

Views per post

Engagement rate per post

What the audience does

Followers by day

Benzer hesaplar